» Articles » PMID: 26448047

An Sp1 Modulated Regulatory Region Unique to Higher Primates Regulates Human Androgen Receptor Promoter Activity in Prostate Cancer Cells

Overview
Journal PLoS One
Date 2015 Oct 9
PMID 26448047
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Androgen receptor (AR) mediated signalling is necessary for normal development of the prostate gland and also drives prostate cancer (PCa) cell growth and survival, with many studies showing a correlation between increased receptor levels and therapy resistance with progression to fatal castrate recurrent PCa (CRPC). Although it has been held for some time that the transcription factor Sp1 is the main stimulator of AR gene transcription, comprehensive knowledge of the regulation of the AR gene remains incomplete. Here we describe and characterise in detail two novel active regulatory elements in the 5'UTR of the human AR gene. Both of these elements contain overlapping binding sites for the positive transcription factor Sp1 and the repressor protein pur-α. Aberrant cell signalling is characteristic of PCa and the transcriptional activity of the AR promoter in PCa cells is dependent upon the relative amounts of the two transcription factors. Together with our corroboration of the dominant role of Sp1, the findings support the rationale of targeting this transcription factor to inhibit tumour progression. This should be of particular therapeutic relevance in CRPC where the levels of the repressor pur-α are reduced.

Citing Articles

Androgens contribute to sex bias of autoimmunity in mice by T cell-intrinsic regulation of Ptpn22 phosphatase expression.

Lee J, Yurkovetskiy L, Reiman D, Frommer L, Strong Z, Chang A Nat Commun. 2024; 15(1):7688.

PMID: 39227386 PMC: 11372096. DOI: 10.1038/s41467-024-51869-7.


Mechanistic insights into steroid hormone-mediated regulation of the androgen receptor gene.

Gillen A, Hunter I, Ullner E, McEwan I PLoS One. 2024; 19(8):e0304183.

PMID: 39088439 PMC: 11293711. DOI: 10.1371/journal.pone.0304183.


AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production.

Tahsin S, Sane N, Cernyar B, Jiang L, Zohar Y, Lee B Oncogene. 2024; 43(27):2092-2103.

PMID: 38769192 PMC: 11702291. DOI: 10.1038/s41388-024-03064-7.


Novel Insights on the Role of Epigenetics in Androgen Receptor's Expression in Prostate Cancer.

Camilo V, Pacheco M, Moreira-Silva F, Outeiro-Pinho G, Gaspar V, Mano J Biomolecules. 2023; 13(10).

PMID: 37892208 PMC: 10605369. DOI: 10.3390/biom13101526.


International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023.

Burris T, de Vera I, Cote I, Flaveny C, Wanninayake U, Chatterjee A Pharmacol Rev. 2023; 75(6):1233-1318.

PMID: 37586884 PMC: 10595025. DOI: 10.1124/pharmrev.121.000436.


References
1.
Wang Q, Li W, Zhang Y, Yuan X, Xu K, Yu J . Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell. 2009; 138(2):245-56. PMC: 2726827. DOI: 10.1016/j.cell.2009.04.056. View

2.
GROSSMANN M, Lindzey J, Kumar M, Tindall D . The mouse androgen receptor is suppressed by the 5'-untranslated region of the gene. Mol Endocrinol. 1994; 8(4):448-55. DOI: 10.1210/mend.8.4.8052266. View

3.
Li L, Davie J . The role of Sp1 and Sp3 in normal and cancer cell biology. Ann Anat. 2010; 192(5):275-83. DOI: 10.1016/j.aanat.2010.07.010. View

4.
Wang L, Ferrari A . Mithramycin targets sp1 and the androgen receptor transcription level-potential therapeutic role in advanced prostate cancer. Transl Oncogenomics. 2013; 1:19-31. PMC: 3642134. View

5.
Chen Z, Lan X, Thomas-Ahner J, Wu D, Liu X, Ye Z . Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer. EMBO J. 2014; 34(4):502-16. PMC: 4331004. DOI: 10.15252/embj.201490306. View